NajatBouchkoujMD

PubMed

• 8 citations
  FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
  Najat Bouchkouj, Xue Lin, Xiaofei Wang, Donna Przepiorka, Zhenzhen Xu, Tejashri Purohit-Sheth, Marc Theoret> ;The Oncologist. 2022 Oct 1
• Regulatory Aspects of Gene Therapy: The Regulatory Life Cycle.
  Najat Bouchkouj, Megha Kaushal, Poornima Sharma, Kristin Baird> ;Hematology/oncology Clinics of North America. 2022 Aug 1
• 3 citations
  FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma.
  Najat Bouchkouj, Megan Zimmerman, Yvette L Kasamon, Cong Wang, Tianjiao Dai, Zhenzhen Xu, Xiaofei Wang, Marc Theoret, Tejashri Purohit-Sheth, Bindu George> ;The Oncologist. 2022 Jul 5
• 16 citations
  Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration w...
  Andrew D.J. Pearson, Claudia Rossig, Crystal L. Mackall, Nirali N. Shah, André Baruchel, Gregory H. Reaman, Rosanna Ricafort, Delphine Heenen, Abraham Bassan, Michael ...> ;European Journal of Cancer. 2021 Nov 25
• 18 citations
  Patient Reported Outcomes in Pediatric Cancer Registration Trials: A U.S. Food and Drug Administration Perspective.
  Meena N Murugappan, Bellinda L King-Kallimanis, Gregory H. Reaman, Vishal Bhatnagar, Erica G. Horodniceanu, Najat Bouchkouj, Paul G. Kluetz> ;Journal of the National Cancer Institute. 2021 Apr 30
• 140 citations
  FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
  Najat Bouchkouj, Yvette L. Kasamon, R. Angelo de Claro, Bindu George, Xue Lin, Shiowjen Lee, Gideon M. Blumenthal, Wilson Bryan, Amy E. McKee, Richard Pazdur> ;Clinical Cancer Research. 2019 Mar 15
• 11 citations
  A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell ...
  Brynn B. Duncan, Steven L. Highfill, Haiying Qin, Najat Bouchkouj, Shannon M. Larabee, Peng Zhao, Iwona Woznica, Yuxin Liu, Youhua Li, Wengen Wu, Jack H. Lai, Barry Jo...> ;Journal of Immunotherapy. 2013 Oct 1
• 8 citations
  Outreach to Immigrant Communities: Teaching Pediatric Residents about Access to Health Care
  Robert J. Karp, David Rhee, David Feldman, Najat Bouchkouj> ;Journal of Health Care for the Poor and Underserved. 2007 Jul 30
• Join now to see all

Abstracts/Posters

• 2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and...
  Najat Bouchkouj, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Regulatory Challenges Related to Cell-Based Therapies. Shepherding Cell Based Cancer Therapeutics Toward Approval 
  2018 ASCO Annual Meeting - Chicago, Illinois - 05/31/2018